Determination of dopamine and dopamine-derived (R)-/(S)-salsolinol and norsalsolinol in various human brain areas using solid-phase extraction and gas chromatography/mass spectrometry

Forensic Science International

Volumn 113, Issue 1-3, 2000, Pages 359-366

  Musshoff, F ^a   Schmidt, P ^a   Dettmeyer, R ^a   Priemer, F ^b   Jachau, K ^c   Madea, B ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Brain; Dopamine; Enantiomeric composition; GC MS analysis; Human; Norsalsolinol; Salsolinol

Indexed keywords

DOPAMINE; NORSALSOLINOL; SALSOLINOL; UNCLASSIFIED DRUG;

ALCOHOLISM; BRAIN REGION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DERIVATIZATION; DRUG DETERMINATION; ENANTIOMER; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; STANDARD; SUBSTANTIA NIGRA;

EID: 0343006752     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0379-0738(00)00225-5     Document Type: Conference Paper

References (29)

1. Cohen G., Collins M. Alkaloids from catecholamines in adrenal tissue: possible role in alcoholism. Science. 167:1970;1749-1751.
2. Davis V.E., Walsh M.J. Alcohol, amines, and alkaloids: a possible biochemical basis for alcohol addiction. Science. 167:1970;1005-1007.
3. Haber H., Melzig M. Tetrahydroisoquinolines - endogenous products from chronic alcohol abuse. Pharmazie. 47:1992;3-7.
4. Brossi A. Mammalian TIQs: products of condensation with aldehydes or pyruvic acids? Prog. Clin. Biol. Res. 90:1982;125-133.
5. Robbins J.H. Alkaloid formation by condensation of biogenic amines with acetaldehyde. Clin. Res. 16:1968;350-350.
6. Maruyama W., Abr T., Toghi H., Dostert P., Naoi M. A dopaminergic neurotoxin, (R)-N-methylsalsolinol, increases in parkinsonian CSF. Ann. Neurol. 40:1996;119-122.
7. Maruyama W., Narabayashi H., Dostert P., Naoi M. Stereospecific occurrence of a parkinsonism-inducing catechol isoquinoline, N-methyl(R)salsolinol, in the human intraventricular fluid. J. Neural Transm. 103:1996;1069-1076.
8. Maruyama W., Sobue G., Matsubara K., Hashizume Y., Dostert P., Naoi M. A dopaminergic neurotoxin, 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl(R)salsolinol, and its oxidation product, 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion, accumulate in the nigro-striatal system of the human brain. Neurosci. Lett. 223:1997;61-64.
9. Naoi M., Maruyama W., Dostert P., Kohda K., Kaiya T. A novel enzyme enantio-selectively synthesizes (R)salsolinol, a precursor of a dopaminergic neurotoxin, N-methyl(R)salsolinol. Neurosci. Lett. 212:1996;183-186.
10. +-like neurotoxin, 1,2-dimethyl-6,7-dihydroxyisoquinolinium ion, in the substantia nigra of human brains. Neurosci. Lett. 235:1997;81-84.
11. Collins A.C., Cashaw J.L., Davis V.E. Dopamine-derived tetrahydroisoquinoline alkaloids - inhibitors of neuroamine metabolism. Biochem. Pharmacol. 22:1973;2337-2348.
12. Heikkila R., Cohen G., Dembiec D. Tetrahydroisoquinoline alkaloids: uptake by rat brain homogenates and inhibition of catecholamine uptake. J. Pharmacol. Exp. Ther. 179:1971;250-258.
13. Meyerson L.R., McMurtrey K.D., Davis V.E. Neuroamine-derived alkaloids: substrate-preferred inhibitors of rat brain monoamine oxidase in vitro. Biochem. Pharmacol. 25:1976;1013-1020.
14. Minami M., Takahashi T., Maruyama W., Takahashi A., Dostert P., Nagatsu T., Naoi M. Inhibition of tyrosine hydroxylase by R and S enantiomers of salsolinol, 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline. J. Neurochem. 58:1992;2097-2101.
15. Weiner C., Collins M. Tetrahydroisoquinolines derived from catecholamines or dopa: effects on brain tyrosine hydroxylase activity. Biochem. Pharmacol. 27:1978;2699-2703.
16. Myers R.D., Melchior C.L. Differential actions on voluntary alcohol intake of tetrahydroisoquinolines or a beta-carboline infused chronically in the ventricle of the rat. Pharmacol. Biochem. Behav. 7:1977;381-392.
17. Nagatsu T. Isoquinoline neurotoxins in the brain and Parkinson's disease. Neurosci. Res. 29:1997;99-111.
18. Naoi M., Maruyama W., Dostert P. Dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines; oxidation and neurotoxicity. Prog. Brain Res. 106:1995;227-239.
19. Naoi M., Maruyama W., Zhang J.H., Takahashi T., Deng Y., Dostert P. Enzymatic oxidation of the dopaminergic neurotoxin, 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, into 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion. Life Sci. 57:1995;1061-1066.
20. Maruyama W., Dostert P., Matsubara K., Naoi M. N-Methyl(R)salsolinol produces hydroxyl radicals: involvement to neurotoxicity. Free Radic. Biol. Med. 19:1995;67-75.
21. Naoi M., Maruyama W., Kasamatsu T., Dostert P. Oxidation of N-methyl(R)salsolinol: involvement to neurotoxicity and neuroprotection by endogenous catechol isoquinolines. J. Neural Transm. Suppl. 52:1998;125-138.
22. Musshoff F., Schmidt P., Dettmeyer R., Priemer F., Wittig H., Madea B. A systematic study of dopamine and dopamine-derived salsolinol and norsalsolinol levels in human brain areas. Forensic Sci. Int. 105:1999;1-11.
23. Schöpf C., Bayerle H. Zur Frage der Biogenese der Isochinolin-alkaloide. Die Synthese des 1-Methyl-6,7-dioxy-1,2,3,4-tetrahydro-isochinolins unter physiologischen Bedingungen. Ann. Chem. 513:1934;190-205.
24. Buck J.S. Some substituted tetrahydroisoquinoline hydrochlorides. J. Am. Chem. Soc. 56:1934;1769-1771.
25. Haber H., Putscher I., Fickel J., Schümann M., Melzig M. Easy preparation of R- and S-salsolinol of high optically purity. Pharmazie. 48:1993;700-702.
26. 14. Helv. Chim. Acta. 41:1958;1512.
27. Haber H., Henklein P., Georgi M., Melzig M.F. Resolution of catecholic tetrahydroisoquinoline enantiomers and the determination of R- and S-salsolinol in biological samples by gas chromatography-mass spectrometry. J. Chromatogr. B. 672:1995;179-187.
28. Müller T., Przuntek H., Kuhn W., Sällström Baum S., Rommelspacher H. No increase of synthesis of (R)salsolinol in Parkinson's disease. Mov. Disord. 14:1999;514-515.
29. Naoi M., Maruyama W., Nakao N., Ibi T., Sahashi K., Strolin Benedetti M. (R)Salsolinol N-methyltransferase activity increases in parkinsonian lymphocytes. Ann. Neurol. 43:1998;212-216.